U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07014631) titled 'Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD' on June 03.
Brief Summary: This study primarily evaluates the efficacy and safety of oral SSS17 capsules in treating anemia in patients with non-dialysis chronic kidney disease, as well as the pharmacokinetic and pharmacodynamic (PK/PD) characteristics of different doses of SSS17 capsules for anemia treatment in this patient population.
Study Start Date: March 01, 2023
Study Type: INTERVENTIONAL
Condition:
Anemia in Pre-Dialysis Patients
Intervention:
DRUG: SSS17
The SSS17 treatment arm comprises three dose levels: the first two dose levels will have an 8-wee...